ArticleScientific reports2026
IL2Pepscan: A machine learning framework for predicting IL-2 inducing peptides and their identification across global viral proteomes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Interleukin-2 (IL-2) is a pivotal cytokine involved in regulating immune responses, particularly in the activation and proliferation of T cells. Interleukin-2 (IL-2) is a key regulator of immune responses, making the identification of IL-2-inducing peptides vital for advancing immunotherapy and vaccine development. In this study, we present a computational approach for predicting IL-2-inducing peptides. Positive and negative peptide datasets were obtained from the Immune Epitope Database (IEDB), and relevant features were extracted using the pfeature, ifeature algorithms and large language models like ProtBERT. Our extra tree based model, developed on Dipeptide deviation from Expected mean (DDE) features, achieves an external validation accuracy of 79.88%, sensitivity of 81.24%, and a Matthews Correlation Coefficient (MCC) of 0.6. This model was then used to predict IL-2 inducing peptides from the global viral RefSeq proteome comprising 14,365 unique viruses encoding 374,209 proteins, yielding 155.68 million peptides. This analysis led to the identification of several promising IL-2-inducing viral encoded candidates. A literature review confirmed that some of the viral proteins encoding these peptides had been experimentally validated to induce IL-2, thereby supporting the reliability of our prediction pipeline. To facilitate broader usage, we have made the tool available through a user-friendly web server ( http://www.soodlab.com/il2pepscan/ ), enabling the scientific community to assess the IL-2-inducing potential of their peptides of interest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.